HEDIS® Results
Medicaid HEDIS® Annual Rates.
Senior Whole Health’s scores for the past two years are below. You can see how Senior Whole Health performs compared to our target goal.
Measure |
2022 |
2023 |
Goal |
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
NA |
NA |
64.90% |
Annual Dental Visits (ADV) Total |
NA |
NA |
54.60% |
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
NA |
83.33% |
46.74% |
Appropriate Testing for Pharyngitis (CWP) |
NA |
NA |
77.56% |
Appropriate Treatment for Upper Respiratory Infection (URI) Total |
NA |
NA |
93.08% |
Asthma Medication Ratio (AMR) Total |
NA |
NA |
69.41% |
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) |
NA |
NA |
66.19% |
Blood Pressure Control (<140/90) for Patients With Diabetes (BPD) |
56.61% |
58.62% |
68.61% |
Breast Cancer Screening (BCS) |
62.63% |
64.80% |
55.25% |
Cervical Cancer Screening (CCS) |
NA |
NA |
59.85% |
Childhood Immunization Status (CIS) Combination #10 |
NA |
NA |
35.04% |
Chlamydia Screening in Women (CHL) Total |
NA |
NA |
61.07% |
Controlling High Blood Pressure (CBP) |
47.69% |
49.15% |
65.45% |
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
NA |
NA |
80.86% |
Eye Exam for Patients With Diabetes (EED) |
52.38% |
70.11% |
56.20% |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
NA |
NA |
27.73% |
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
NA |
NA |
46.35% |
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
NA |
NA |
41.03% |
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total |
NA |
NA |
37.31% |
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
NA |
NA |
57.90% |
Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%) |
68.25% |
58.05% |
55.72% |
Immunizations for Adolescents (IMA) Combination #2 |
NA |
NA |
38.93% |
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total |
NA |
NA |
16.94% |
Kidney Health Evaluation for Patients with Diabetes (KED) |
46.04% |
43.15% |
38.80% |
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total |
NA |
NA |
39.01% |
Pharmacotherapy for Opioid Use Disorder (POD) Total |
NA |
NA |
31.93% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
NA |
NA |
75.79% |
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
NA |
NA |
86.96% |
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years |
NA |
NA |
≤ 92.72% |
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
NA |
NA |
86.86% |
Prenatal and Postpartum Care (PPC) Postpartum Care |
NA |
NA |
80.78% |
Prenatal Immunization Status (PRS) Combination Rate |
NA |
NA |
25.81 |
Risk of Continued Opioid Use (COU) 31-Day Total |
3.33% |
16.39% |
≤ 2.45% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
NA |
NA |
81.64% |
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
NA |
NA |
73.63% |
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
90.09% |
85.44% |
67.07% |
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
17.00% |
85.23% |
70.37% |
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
NA |
NA |
63.89% |
Use of Imaging Studies for Low Back Pain (LBP) |
NA |
NA |
75.44% |
Use of Opioids at High Dosage (HDO) |
NA |
NA |
≤ 2.19% |
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
0% |
0% |
≤ 0.87% |
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
NA |
NA |
83.21% |
NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate